Quality of life assessment in advanced pancreatic adenocarcinoma: Results from a phase III randomized trial-Reference-Cited by-同舟云学术

Quality of life assessment in advanced pancreatic adenocarcinoma: Results from a phase III randomized trial

Published:2006-10 Issue:5 Volume:6 Page:454-463
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Reni Michele,Bonetto Elisa,Cordio Stefano,Passoni Paolo,Milandri Carlo,Cereda Stefano,Spreafico Anna,Galli Laura,Bordonaro Roberto,Staudacher Carlo,Di Carlo Valerio,Johnson Colin D.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference31 articles.

1. Perspectives in chemotherapy of pancreatic cancer;Klapdor;Eur J Surg Oncol,1991

2. Should further studies of chemotherapy be carried out in pancreatic cancer?;Taylor;Eur J Cancer,1993

3. No standard treatment is available for advanced pancreatic cancer;Lionetto;Eur J Cancer,1995

4. Chemotherapy prolongs survival in inoperable pancreatic carcinoma;Palmer;Br J Surg,1994

5. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer;Glimelius;Ann Oncol,1996

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine maintenance versus observation after first-line chemotherapy in patients with metastatic urothelial carcinoma: a retrospective study;Translational Andrology and Urology;2020-10

2. A Case Report of Partial Remission of End-stage Pancreatic Cancer Patient with Liver Metastasis Treated with Chemotherapy and Integrated Medicine Therapy;The Journal of Internal Korean Medicine;2020-05-30

3. Population-Level Symptom Assessment Following Pancreaticoduodenectomy for Adenocarcinoma;JAMA Surgery;2019-11-20

4. Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial;Cancer Medicine;2019-07-17

5. Patient-Reported Physical Function Measures in Cancer Clinical Trials;Epidemiologic Reviews;2017-01-01